Shannon M Nugent1,2, Sara E Golden3, Charles R Thomas4, Mark E Deffebach5,6, Mithran S Sukumar7, Paul H Schipper7, Brandon H Tieu7, Drew Moghanaki8, Juan Wisnivesky9, Christopher Slatore3,4,5,6. 1. Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D66), 3710 SW US Veterans Hospital Road, Portland, OR, 97239, USA. Shannon.nugent@va.gov. 2. Division of Psychiatry, Oregon Health & Science University, Portland, OR, USA. Shannon.nugent@va.gov. 3. Center to Improve Veteran Involvement in Care, VA Portland Health Care System (R&D66), 3710 SW US Veterans Hospital Road, Portland, OR, 97239, USA. 4. Department of Radiation Medicine, Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA. 5. Division of Pulmonary & Critical Care Medicine, Department of Medicine, Oregon Health & Science University, Portland, OR, USA. 6. Section of Pulmonary & Critical Care Medicine, VA Portland Health Care System, Portland, OR, USA. 7. Division of Cardiothoracic Surgery, Department of Surgery, Oregon Health & Science University, Portland, OR, USA. 8. Division of Clinical Research, Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, VA, USA. 9. Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Abstract
PURPOSE: Limited data exist about patient-centered communication (PCC) and patient-centered outcomes among patients who undergo surgery or stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC). We aimed to examine the relationship between PCC and decision-making processes among NSCLC patients, using baseline data from a prospective, multicenter study. METHODS: Patients with stage 1 NSCLC completed a survey prior to treatment initiation. The survey assessed sociodemographic characteristics, treatment decision variables, and patient psychosocial outcomes: health-related quality of life (HRQOL), treatment self-efficacy, decisional conflict, and PCC. RESULTS: Fifty-two percent (n = 85) of 165 individuals planned to receive SBRT. There were no baseline differences detected on patient psychosocial outcomes between those who planned to receive SBRT or surgery. All participants reported high HRQOL (M = 72.5, SD = 21.3) out of 100, where higher scores indicate better functioning; high self-efficacy (M = 1.5, SD = 0.5) out of 6, where lower numbers indicate higher self-efficacy; minimal decisional conflict (M = 15.2, SD = 12.7) out of 100, where higher scores indicate higher decisional conflict; and high levels of patient-centered communication (M = 2.4, SD = 0.8) out of 7 where higher scores indicate worse communication. Linear regression analyses adjusting for sociodemographic and clinical variables showed that higher quality PCC was associated with higher self-efficacy (β = 0.17, p = 0.03) and lower decisional conflict (β = 0.42, p < 0.001). CONCLUSIONS: Higher quality PCC was associated with higher self-efficacy and lower decisional conflict. Self-efficacy and decisional conflict may influence subsequent health outcomes. Therefore, our findings may inform future research and clinical programs that focus on communication strategies to improve these outcomes.
PURPOSE: Limited data exist about patient-centered communication (PCC) and patient-centered outcomes among patients who undergo surgery or stereotactic body radiation therapy (SBRT) for stage I non-small cell lung cancer (NSCLC). We aimed to examine the relationship between PCC and decision-making processes among NSCLCpatients, using baseline data from a prospective, multicenter study. METHODS:Patients with stage 1 NSCLC completed a survey prior to treatment initiation. The survey assessed sociodemographic characteristics, treatment decision variables, and patient psychosocial outcomes: health-related quality of life (HRQOL), treatment self-efficacy, decisional conflict, and PCC. RESULTS: Fifty-two percent (n = 85) of 165 individuals planned to receive SBRT. There were no baseline differences detected on patient psychosocial outcomes between those who planned to receive SBRT or surgery. All participants reported high HRQOL (M = 72.5, SD = 21.3) out of 100, where higher scores indicate better functioning; high self-efficacy (M = 1.5, SD = 0.5) out of 6, where lower numbers indicate higher self-efficacy; minimal decisional conflict (M = 15.2, SD = 12.7) out of 100, where higher scores indicate higher decisional conflict; and high levels of patient-centered communication (M = 2.4, SD = 0.8) out of 7 where higher scores indicate worse communication. Linear regression analyses adjusting for sociodemographic and clinical variables showed that higher quality PCC was associated with higher self-efficacy (β = 0.17, p = 0.03) and lower decisional conflict (β = 0.42, p < 0.001). CONCLUSIONS: Higher quality PCC was associated with higher self-efficacy and lower decisional conflict. Self-efficacy and decisional conflict may influence subsequent health outcomes. Therefore, our findings may inform future research and clinical programs that focus on communication strategies to improve these outcomes.
Authors: Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy Journal: JAMA Date: 2010-03-17 Impact factor: 56.272
Authors: Christopher G Slatore; Nancy Press; David H Au; J Randall Curtis; Renda Soylemez Wiener; Linda Ganzini Journal: Ann Am Thorac Soc Date: 2013-08
Authors: Joe Y Chang; Suresh Senan; Marinus A Paul; Reza J Mehran; Alexander V Louie; Peter Balter; Harry J M Groen; Stephen E McRae; Joachim Widder; Lei Feng; Ben E E M van den Borne; Mark F Munsell; Coen Hurkmans; Donald A Berry; Erik van Werkhoven; John J Kresl; Anne-Marie Dingemans; Omar Dawood; Cornelis J A Haasbeek; Larry S Carpenter; Katrien De Jaeger; Ritsuko Komaki; Ben J Slotman; Egbert F Smit; Jack A Roth Journal: Lancet Oncol Date: 2015-05-13 Impact factor: 41.316
Authors: Hubert Pan; Brent S Rose; Daniel R Simpson; Loren K Mell; Arno J Mundt; Joshua D Lawson Journal: Am J Clin Oncol Date: 2013-06 Impact factor: 2.339
Authors: Alan L Kaplan; Catherine M Crespi; Josemanuel D Saucedo; Sarah E Connor; Mark S Litwin; Christopher S Saigal Journal: Cancer Date: 2014-05-09 Impact factor: 6.860
Authors: Alexander V Louie; Erik van Werkhoven; Hanbo Chen; Egbert F Smit; Marinus A Paul; Joachim Widder; Harry J M Groen; Ben E E M van den Borne; Katrien De Jaeger; Ben J Slotman; Suresh Senan Journal: Radiother Oncol Date: 2015-10 Impact factor: 6.280
Authors: Donald R Sullivan; Karen B Eden; Nathan F Dieckmann; Sara E Golden; Kelly C Vranas; Shannon M Nugent; Christopher G Slatore Journal: Lung Cancer Date: 2019-03-09 Impact factor: 5.705
Authors: Shannon M Nugent; Sara E Golden; Donald R Sullivan; Charles R Thomas; Juan Wisnivesky; Somnath Saha; Christopher G Slatore Journal: Med Oncol Date: 2022-09-29 Impact factor: 3.738
Authors: Rebecca M Schwartz; Rowena Yip; Nan You; Christina Gillezeau; Kimberly Song; David F Yankelevitz; Emanuela Taioli; Claudia I Henschke; Raja M Flores Journal: MDM Policy Pract Date: 2022-03-21